|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 13, 2009
doi: 10.1242/10.1242/dev.018234
Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec H3A 2B4, Canada.
* Author for correspondence (e-mail: timothy.kennedy{at}mcgill.ca)
Accepted 21 November 2008
| SUMMARY |
|---|
|
|
|---|
Key words: Oligodendroglia, Myelination, Myelin, Netrin, Integrin, Laminin, Autocrine, Mouse, Rat, FAK (Ptk2), N-WASP (Wasl)
| INTRODUCTION |
|---|
|
|
|---|
Laminin 2, which promotes oligodendrocyte maturation by signaling through
6β1 integrins (Baron et al.,
2005
), has been suggested to regulate process elaboration.
Laminin-2-deficient mice have dysmyelinated and hypomyelinated axons
(Chun et al., 2003
). However,
laminin 2 is not ubiquitous in myelinated CNS axon tracts
(Colognato et al., 2002
) and
transgenic mice lacking β1 integrin expression in oligodendrocytes
exhibit no defects in CNS myelination
(Benninger et al., 2006
). Thus,
other ligand-receptor interactions must also direct the changes in
oligodendrocyte morphology required for myelination.
The axon-guidance cue netrin 1 (Ntn1) is a chemorepellent for migrating
oligodendrocyte precursors (OPCs) in the embryonic spinal cord
(Jarjour et al., 2003
;
Tsai et al., 2003
). These
cells express the netrin 1 receptors Dcc, Unc5a and Unc5b, but not netrin 1
itself. In the adult CNS, netrin 1 is expressed by myelinating
oligodendrocytes and is associated with non-compacted oligodendroglial
membranes (Manitt et al.,
2001
). We therefore investigated the possibility that netrin 1,
expressed in the developing CNS and later by the oligodendrocytes themselves,
might influence late stages of oligodendrocyte differentiation.
The lamella elaborated by the tip of an extending oligodendrocyte process
has been compared to a neuronal growth cone
(Fox et al., 2006
;
Jarjour and Kennedy, 2004
;
Sloane and Vartanian, 2007
).
Interestingly, a number of the same intracellular signaling proteins have been
implicated in netrin-1-mediated axon guidance and the development of
oligodendrocyte processes required for myelination
(Fox et al., 2006
;
Jarjour and Kennedy, 2004
). In
both cases, the reorganization of the actin cytoskeleton requires activation
of the Src family kinase (SFK) Fyn
(Meriane et al., 2004
;
Osterhout et al., 1999
;
Umemori et al., 1994
) and
involves Wiscott-Aldrich syndrome protein (N-WASP; Wasl - Mouse Genome
Informatics) and Rho GTPases (Bacon et al.,
2007
; Liang et al.,
2004
; Shekarabi et al.,
2005
).
Here we provide evidence that netrin 1 and Dcc promote the extension of oligodendrocyte processes in vivo. We used in vitro assays to demonstrate that netrin 1 increases oligodendrocyte process branching. Furthermore, expression of Dcc and netrin 1 by oligodendrocytes promotes the formation of myelin-like membrane sheets. Addressing the signaling mechanisms involved, we show that the SFK Fyn is required for netrin-1-induced process branching, that netrin 1 recruits Fyn to Dcc in oligodendrocytes, increases SFK activity, and promotes process extension and branching associated with a decrease in RhoA activity. Our findings reveal a novel role for netrin 1 and Dcc in activating a signaling cascade in oligodendrocytes that directs process remodeling.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture
OPCs were derived from mixed glial cultures from the cerebral cortices of
postnatal day 0 (P0) rat pups and grown in oligodendrocyte defined medium
(OLDEM) as described previously (Armstrong,
1998
; Jarjour et al.,
2003
), with 0.1% fetal bovine serum (FBS) to initiate
differentiation. Cells were seeded at 1.5x104 cells/chamber
in 8-well chamber slides coated with 10 µg/ml poly-L-lysine
(Nalge Nunc, Rochester, NY, USA). For immunoprecipitation, western blots and
GST-rhotekin pulldowns, cells were plated at 1.5x106
cells/well in 6-well tissue culture dishes.
Mouse oligodendrocyte cultures
Culturing of mouse OPCs was similar to that of rat OPCs, but 10% horse
serum was used instead of 10% FBS in mixed glial culture media. Each T75 flask
of mixed glial culture required two to three pups. Newborn
Ntn1-/- and Dcc-/- mice were
identified by distinct behaviors. The genotype of individual pups was
confirmed by PCR.
Antibodies
Primary antibodies used in this study were: rabbit polyclonal anti-netrin 1
PN3 (Manitt et al., 2001
),
mouse monoclonal anti-Dcc (G97-449; BD Biosciences Pharmingen, San Jose, CA,
USA), goat polyclonal anti-Dcc (Santa Cruz Biotech, Santa Cruz, CA, USA),
rabbit polyclonal anti-myelin basic protein (Mbp, Chemicon, Temecula, CA,
USA), mouse monoclonal anti-Mbp (Chemicon), mouse monoclonal RIP antibody
(Chemicon), mouse monoclonal anti-2',3'-cyclic nucleotide 3'
phosphodiesterase (Cnp, Sternberger Monoclonals, Lutherville, MD, USA), rabbit
polyclonal anti-Mag (Chemicon), rabbit polyclonal anti-Nfm (Nefm - Mouse
Genome Informatics) (Chemicon), rabbit polyclonal anti-Fyn (Upstate Cell
Signaling, Charlottesville, VA, USA) used for western blots, rabbit polyclonal
anti-Fyn [gift of Dr Andre Veillete and described previously
(Davidson et al., 1992
)] used
for immunoprecipitation and western blots, mouse monoclonal anti-FAK (BD
Biosciences), rabbit polyclonal anti-N-WASP (Santa Cruz), and rabbit
polyclonal anti-phospho-Src (Cell Signaling), which recognizes the pY416
epitope in all SFK members.
For analyses of oligodendrocyte morphology in vivo, we crossed Ntn1 or Dcc heterozygous mice, obtained embryonic day 18 (E18) embryos (plug date taken as E1), fixed them in 4% paraformaldehyde and cut 18 µm sections of the spinal brachial enlargement with a cryostat. Sections were then stained with anti-Cnp (1:250), anti-Nfm (1:250), anti-netrin PN3 (1:100), visualized using Alexa 546- or Alexa 488-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA), and nuclei stained with Hoechst. Images were obtained with a Magnafire CCD camera (Optronics, Goleta, CA, USA) and a Zeiss Axiovert 100 microscope (Toronto, Ontario, Canada).
Analysis of oligodendrocyte morphology
Analyses of immature oligodendrocytes in vitro and in vivo were performed
using the NeuronJ plugin for ImageJ (NIH, Bethesda, MD, USA). The length of
the longest process was measured from the base of the process to its tip
(Fig. 3D;
Fig. 4B). For Sholl analysis,
the grid function in Northern Eclipse (Empix) was used to draw concentric
circles 15 µm apart around the cell body of mature RIP-positive
oligodendrocytes. The number of intersections made by processes with each
successive circle was counted. For studies using the β1 integrin subunit
function-blocking antibody and mouse oligodendrocyte cultures, a Sholl
analysis plugin was used with ImageJ (starting radius, 1.02 cm; step size,
1.02 cm; end, 5.08 cm; thickness, 0.02 cm). The Mbp-positive myelin-like
membrane sheets were outlined in ImageJ and the surface area reported in
arbitrary units.
The pharmacological inhibitors PP2 and PP3 (Calbiochem) were used at 2 µM to inhibit SFK activity. Purified hamster anti-rat CD29 (β1 integrin) monoclonal and purified hamster anti-IgM monoclonal antibodies were used at 2 µM to investigate β1 integrin function.
Analysis of phospho-Src puncta
The number of phospho-Src-positive puncta was measured using ImageJ. The
brightness and contrast of the images of individual oligodendrocytes were
modified to enhance puncta associated with extending processes; modifications
made were consistent across all images. Images were converted to a binary
format and then the number of particles counted automatically. Staining in the
cell body and major processes was not punctate and thus counted as one
particle, making variations under different conditions a direct indicator of
changes in the number of distally located puncta. The number of puncta was
divided by oligodendrocyte area to control for variance in oligodendrocyte
size.
Quantification and statistical analyses
Statistical significance was calculated by ANOVA followed by a post-hoc
Tukey test using Systat Software (San Jose, CA, USA). Analyses of
oligodendrocyte morphology in vitro used three independent experiments with a
minimum of 30 cells per condition. In vivo analysis of process extension and
purification of oligodendrocytes from transgenic mice were performed using at
least four pups of each genotype, derived from at least two different
litters.
Immunoprecipitation
Cells in 6-well dishes were treated with netrin 1 for 5 minutes, then lysed
in RIPA lysis buffer (10 mM sodium phosphate pH 7.2, 150 mM NaCl, 1% NP40,
0.1% SDS, 0.5% deoxycholate) and centrifuged at 13,000 rpm (13,800
g) for 7 minutes. Supernatant was pre-cleared with 30 µl
protein A/G beads (Santa Cruz) for 30 minutes, incubated with 1 µg/ml
anti-Dcc (monoclonal) or anti-Fyn (rabbit polyclonal) for 1 hour, followed by
addition of 30 µl protein A/G beads for 45 minutes.
GST pulldown assays
Fusion proteins comprising the RhoA-binding domain of rhotekin (a
downstream substrate of RhoA) or Pak-CRIB and glutathione-S-transferase (GST)
were purified as described (Reid et al.,
1996
). Oligodendrocytes were treated with netrin 1 for 24 hours.
Cells were then lysed and protein purified as described
(Ren and Schwartz, 2000
;
Shekarabi et al., 2005
).
| RESULTS |
|---|
|
|
|---|
To determine when netrin 1 is expressed by differentiating
oligodendrocytes, we performed a time-course analysis. Premyelinating,
postmigratory oligodendrocytes within the corticospinal tract at brachial,
thoracic and lumbar levels were examined. Netrin 1 expression was not detected
in oligodendrocytes at embryonic stages of development in mice (data not
shown). For postnatal stages, netrin-1-expressing cells were identified
immunohistochemically. Oligodendrocytes in the developing dorsolateral white
matter tracts were identified by expression of 2',3'-cyclic
nucleotide 3' phosphodiesterase (Cnp), a marker that labels
oligodendrocyte cell bodies and processes in vivo, and by expression of the
mature oligodendrocyte marker myelin basic protein (Mbp). At P8, before
myelination begins in the corticospinal tract, netrin 1 was not expressed by
premyelinating oligodendrocytes (Fig.
1A-C). Netrin-1-expressing neuronal cell bodies and
neural-epithelial cells (Fig.
1D,E), but not astrocytes (Fig.
1I), were detected immediately adjacent to differentiating
oligodendrocytes. At P12, following the initiation of myelination in the rat
corticospinal tract (Schwab and Schnell,
1989
), netrin 1 was detected in the cell bodies of a subset of
oligodendrocytes double labeled with Cnp
(Fig. 1F,G). At this stage of
development, netrin 1 immunoreactivity was associated with axons
(Fig. 1I). By P22, large
numbers of mature myelinating oligodendrocytes expressing netrin 1 were
readily detectable throughout the nascent white matter of the spinal cord
(Fig. 1J,K). These findings
indicate that netrin 1 begins to be expressed by oligodendrocytes during early
stages of myelination.
|
The netrin 1 receptor Dcc was detected along the processes of immature and mature oligodendrocytes. In mature oligodendrocytes, Dcc was associated with major branches and present in small puncta at the leading edge of myelin-like membrane sheets (Fig. 2B). Addition of recombinant Myc-tagged netrin 1 to mature oligodendrocytes revealed a preferential localization of exogenous ligand at the branches and edges of sheets formed by the cells, similar to the distribution of Dcc (Fig. 2A',B').
Netrin 1 and Dcc promote process extension by premyelinating oligodendrocytes in vivo
In the developing spinal cord, as premyelinating oligodendrocytes mature
into myelinating oligodendrocytes, netrin 1 is widely expressed by neurons and
neuroepithelial cells, but not by oligodendrocytes
(Fig. 1D,I;
Fig. 3C). Mice lacking either
netrin 1 or Dcc die within hours of birth
(Fazeli et al., 1997
;
Serafini et al., 1996
). We
therefore used E18 littermates to compare the morphology of postmigratory,
premyelinating oligodendrocytes in tissue sections from the spinal cords of
wild-type and Ntn1 and Dcc heterozygotes and knockout mouse
embryos (Fig. 3A-C). At E18,
Cnp-immunoreactive premyelinating oligodendrocytes in the dorsolateral spinal
cord typically extend one or more processes
(Fig. 3D, dashed lines). We
found the length of these processes in both Ntn1-/- and
Dcc -/- mice to be significantly shorter than in wild-type
littermates (Fig. 3E,F). These
findings provide evidence that at the end of precursor migration and at the
initiation of oligodendrocyte differentiation, netrin 1 in the local
environment of a postmigratory, premyelinating oligodendrocyte promotes
Dcc-dependent process extension in vivo, a phenomenon closely associated with
the capacity of an oligodendrocyte to contact target axons
(Hardy and Friedrich, 1996
;
Kirby et al., 2006
).
|
Netrin 1 does not affect the differentiation of immature or mature oligodendrocytes in vitro
Distinct changes in oligodendrocyte morphology accompany the
differentiation of oligodendrocytes in vitro. Immature oligodendrocytes are
characteristically multipolar cells that express Cnp but not Mbp
(Fig. 4A,B). These cells
differentiate into mature oligodendrocytes that elaborate myelin-like membrane
sheets and express both Mbp and Cnp (Fig.
4A,D), and eventually myelin-associated glycoprotein (Mag).
Immature cells (4-5 DIV) grown in the presence of netrin 1 (100 ng/ml) for 24
hours showed a modest (4%) decrease in the ratio of Cnp- to Mbp-positive
cells. In more-mature Mbp/Mag-positive cultures (6-8 DIV), the ratio of
Mbp-positive cells to Mag-positive cells was not affected by the addition of
netrin 1 (Fig. 4A). We conclude
that the addition of netrin 1 in vitro does not alter the acquisition of a
mature phenotype, as assessed by the expression of standard markers.
Netrin 1 induces Dcc-dependent process extension by immature oligodendrocytes in vitro
The effect of netrin 1 on process extension, as assayed by measuring the
length of the longest process, was investigated in Cnp-immunopositive immature
oligodendrocytes in culture (Fig.
4B). Application of 100 ng/ml netrin 1 for 24 hours to immature
oligodendrocytes increased process length compared with control cells
(Fig. 4C). To determine whether
Dcc is required for netrin-1-induced extension of oligodendrocyte processes in
vitro, a Dcc function-blocking antibody (Dccfb) was added for 24 hours to
immature oligodendrocytes treated with netrin 1. Consistent with the findings
obtained in vivo and described above (Fig.
3F), disruption of Dcc function blocked the netrin-1-induced
increase in process length, but did not significantly alter process extension
when added alone (Fig. 4C). We
conclude that the application of netrin 1 promotes Dcc-dependent
oligodendrocyte process extension, and that these changes occur independently
of defects in migration and axon growth.
Netrin 1 promotes Dcc-dependent increases in oligodendrocyte branching and myelin-like sheet formation
To investigate roles for netrin 1 during later stages of oligodendrocyte
development, we characterized changes in oligodendrocyte process branching and
in the capacity of these cells to elaborate myelin-like membrane sheets in
vitro. Mature oligodendrocytes cultured for 6-8 DIV were double labeled with
RIP antibody (against Cnp) to identify major processes, and Mbp antibody to
visualize extended myelin-like membrane sheets
(Fig. 4D, left).
Oligodendrocytes grown in the presence of 100 ng/ml netrin 1 for 24 hours
exhibited a significant increase in the area of Mbp-positive sheets
(Fig. 4E). The morphological
complexity of oligodendrocyte processes was quantified using Sholl analysis
(Ricard et al., 2001
)
(Fig. 4D). Cells treated with
100 ng/ml netrin 1 for 24 hours exhibited a significant increase in branching
compared with the control (Fig.
4F,G). A dose-response analysis determined 100 ng/ml netrin 1 to
be optimal (Fig. 4F).
As described above, immunocytochemical analyses detected Dcc, but little, if any, netrin 1 associated with the branches of oligodendrocyte processes. Both Nfb (netrin function-blocking antibody) and Dccfb antibodies blocked the increase in myelin-like membrane sheet formation and process branching induced by the addition of exogenous netrin 1 (Fig. 4E,G), indicating that the netrin-1-induced changes in oligodendrocyte morphology are Dcc-dependent. Substantial netrin 1, but not Dcc, immunoreactivity was detected in association with the myelin-like membrane sheets (Fig. 2A); however, function-blocking antibodies applied in the absence of netrin 1 did not alter sheet formation or process branching (Fig. 4E,G). We therefore tested the hypotheses that netrin 1 made by oligodendrocytes does not exert an autocrine influence on the formation of myelin-like membrane sheets, and, alternatively, that the relatively short-term (24 hours) loss-of-function assays described above are too brief to reveal a role for endogenous netrin 1.
|
By contrast, oligodendrocytes lacking either netrin 1 or Dcc exhibited a significantly reduced surface area of the myelin-like membrane sheets compared with cells derived from wild-type or heterozygote littermates (Fig. 5D,E), thereby identifying an autocrine role for netrin 1 in sheet formation. This is consistent with our demonstration that the addition of exogenous netrin 1 increases myelin-like membrane sheet formation through a Dcc-dependent mechanism (Fig. 4E). These findings reveal differences between the response of oligodendrocytes to netrin 1 made by the cells themselves, which regulates myelin-like membrane sheet formation, and netrin 1 encountered in the local environment, which primarily influences process branching.
Process elaboration induced by netrin 1 does not require β1 subunit-containing integrins
Oligodendrocytes express
vβ1,
vβ3,
vβ5
and
6β1 integrins. Engagement of integrins, specifically
6β1, by extracellular matrix (ECM) components activates SFKs to
regulate changes in oligodendrocyte morphology
(Baron et al., 2005
). Netrins
are members of the laminin family of ECM proteins, and netrin 1 has been
proposed to function as a ligand for
3β1 and
6β4
integrins in pancreatic cells (Yebra et
al., 2003
). We therefore investigated whether netrin-1-mediated
changes in the elaboration of oligodendrocyte processes involve an interaction
between netrin 1 and integrins.
|
6β4
and
3β1 integrins, and hypothesized that potential interactions
between netrin 1 and other integrins might also occur through this region
(Yebra et al., 2003
|
|
SFK activity is required for the netrin-1-induced increase in oligodendrocyte process length and branching
Immunocytochemistry revealed SFK phospho-Y416 immunoreactivity distributed
within the oligodendrocyte cell body and proximal branches, and punctate
staining within the distal branches (Fig.
8C,D). Colocalization with Dcc was observed, consistent with our
immunoprecipitation results (Fig.
7B). To determine whether changes in SFK phosphorylation occurred
upon netrin 1 stimulation, the relative number of SFK
phospho-Y416-immunoreactive puncta was measured per unit area of the cell
(Fig. 8E). Treatment of mature
oligodendrocytes with netrin 1 (100 ng/ml) for 24 hours significantly
increased the number of SFK phospho-Y416-positive puncta per unit area,
consistent with an association between netrin 1 stimulation and increased SFK
activity (Fig. 8F). Treatment
with the SFK inhibitor PP2 (2 µM)
(Hanke et al., 1996
) blocked
the netrin-1-induced increase in SFK phospho-Y416-positive puncta
(Fig. 8F), whereas the inactive
SFK inhibitor analog PP3 (2 µM) had no significant effect on the number of
puncta per unit area (Fig. 8F).
Application of PP2 alone led to a decrease in the relative number of puncta
per unit area, consistent with constitutive SFK activity contributing to the
basal level of puncta observed (Fig.
8F). To exclude the possibility that the increase in SFK
phospho-Y416-positive puncta was secondary to increased branch formation, the
same quantification was performed with cells immunostained for Fyn. No
difference was found in the number of Fyn-immunopositive puncta per unit area
in control and netrin-1-treated cells (Fig.
8G), consistent with the increase in SFK phospho-Y416-positive
puncta resulting from an increase in SFK activity and not a netrin-1-induced
increase in the number of branches.
Our findings indicate that netrin 1 recruits Fyn to a complex with Dcc, increasing SFK activity in oligodendrocytes. We then tested the hypothesis that SFK activation is required for the morphological changes induced by netrin 1. SFK activity was assessed in both immature (4 DIV, Cnp-positive) and mature (6 DIV, Mbp-positive) oligodendrocytes. Treatment of oligodendrocytes with PP2 blocked netrin-1-induced process extension in Cnp-immunoreactive immature cells and the netrin-1-dependent increase in branching in Mbp-expressing mature oligodendrocytes, whereas the inactive analog PP3 had no effect (Fig. 8H,I). Immature oligodendrocytes treated with PP2 alone showed a small but significant decrease in process length (Fig. 8H), which was not seen with PP3 treatment. Mature oligodendrocytes appeared less sensitive to the inhibition of basal SFK activity than immature cells, as PP2 alone did not affect branching (Fig. 8I). We conclude that netrin 1 binding to Dcc results in the recruitment of the SFK Fyn, and that subsequent activation of Fyn is required for the netrin-1-induced changes in oligodendrocyte morphology.
Netrin 1 inhibits RhoA but does not affect Cdc42 or Rac1 in oligodendrocytes
We next asked what signals might act downstream of SFKs to trigger the
morphological changes induced by netrin 1 in oligodendrocytes. Members of the
Rho family of small GTPases, including RhoA, Rac1 and Cdc42, regulate the
elaboration and branching of oligodendrocyte processes
(Liang et al., 2004
). The
effect of netrin 1 on Cdc42 and Rac1 activity was investigated using a
GST-Pak-CRIB pulldown assay (Sander et
al., 1998
). Cell lysates of cultured mature oligodendrocytes were
incubated with GST-Pak-CRIB fusion protein to quantify the levels of GTP-bound
Cdc42 and Rac1. No significant change in the levels of GTP-bound Rac1 or Cdc42
was detected in oligodendrocytes following application of netrin 1
(Fig. 9B,C). We have reported
that the Cdc42 effector protein N-WASP is recruited into a protein complex
with the intracellular domain of Dcc following the addition of netrin 1 to
embryonic spinal commissural neurons
(Shekarabi et al., 2005
).
Unlike in oligodendrocytes, netrin 1 activates Cdc42 and Rac1 in commissural
neurons. In mature oligodendrocytes, N-WASP also constitutively
co-immunoprecipitated with Dcc; however, addition of netrin 1 did not
significantly alter the amount of N-WASP associated with Dcc
(Fig. 9D), which is consistent
with netrin 1 not increasing the activation of Cdc42 in oligodendrocytes.
|
| DISCUSSION |
|---|
|
|
|---|
Exogenous and autocrine netrin 1 contribute to oligodendrocyte maturation
Our results support the conclusion that netrin 1, as expressed by neurons
and neuroepithelial cells, when encountered by a premyelinating
oligodendrocyte evokes Dcc-dependent extension of the motile processes of the
cell. In more mature cells, exogenous netrin 1 promotes Dcc-dependent process
branching and myelin-like membrane sheet formation. Based on our findings in
vitro and in vivo, we hypothesize that by promoting the morphological
maturation of oligodendrocytes, netrin 1 facilitates the search for
appropriate axonal targets. Interestingly, although exogenous netrin 1
promotes changes in oligodendrocyte morphology, at later stages of maturation
oligodendrocytes themselves begin to express netrin 1. We identify a
selective, Dcc-dependent autocrine role for netrin 1 in promoting the
formation of myelin-like membrane sheets. Oligodendrocytes only begin to
express netrin 1 in the developing spinal cord after myelination has begun.
Our findings indicate that contact with axons is not essential for the
initiation of netrin 1 expression by these cells, but that it occurs
coincident with myelin-like membrane sheet formation. We hypothesize that
autocrine expression of netrin 1 specifically promotes later stages of
maturation, facilitating the formation of large myelin-like membrane sheets by
these cells. Netrin 1 expression by oligodendrocytes might also facilitate
axon remodeling or prevent aberrant axonal sprouting at later stages of
development.
|
|
Netrin 1 activates a canonical signaling mechanism required for oligodendrocyte maturation
To date, the candidate extracellular signals that might regulate the
elaboration of oligodendroglial processes immediately preceding myelination
have been limited to ECM proteins, of which laminin 2 and its receptor
integrin
6β1 have been well characterized. Studies in vitro have
shown that integrin-dependent activation of Fyn activates Cdc42 and Rac1 and
deactivates RhoA, leading to process outgrowth
(Liang et al., 2004
;
Osterhout et al., 1999
).
However, oligodendrocytes lacking the β1 integrin subunit mature and
myelinate normally, demonstrating that this pathway is not essential in vivo
(Benninger et al., 2006
).
Furthermore, laminin 2 is not ubiquitously present in myelinating axon tracts
in the CNS, indicating that other ligand-receptor complexes must trigger these
signaling mechanisms independently of β1 integrin function. Our results
show that netrin 1, acting through Dcc, activates an intracellular signaling
pathway that is required for the morphological maturation of oligodendrocytes.
Crucially, the effects of netrin 1 do not require β1 integrin function
and do not appear to act through netrin-binding integrins.
Our findings identify a novel mechanism regulating oligodendrocyte
morphology during later stages of differentiation. Interestingly, many
oligodendroglial cells detected in multiple sclerosis lesions appear to have
differentiated, but remain unable to elaborate myelin
(Chang et al., 2002
). A better
understanding of the mechanisms that promote myelination will advance the
development of therapeutics that aim to promote the recovery of nervous system
function.
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Armstrong, R. C. (1998). Isolation and
characterization of immature oligodendrocyte lineage cells.
Methods 16,282
-292.[CrossRef][Medline]
Bacon, C., Lakics, V., Machesky, L. and Rumsby, M.
(2007). N-WASP regulates extension of filopodia and processes by
oligodendrocyte progenitors, oligodendrocytes, and Schwann cells-implications
for axon ensheathment at myelination. Glia
55,844
-858.[CrossRef][Medline]
Baron, W., Colognato, H. and ffrench-Constant, C.
(2005). Integrin-growth factor interactions as regulators of
oligodendroglial development and function. Glia
49,467
-479.[CrossRef][Medline]
Benninger, Y., Colognato, H., Thurnherr, T., Franklin, R. J.,
Leone, D. P., Atanasoski, S., Nave, K. A., Ffrench-Constant, C., Suter, U. and
Relvas, J. B. (2006). Beta1-integrin signaling mediates
premyelinating oligodendrocyte survival but is not required for CNS
myelination and remyelination. J. Neurosci.
26,7665
-7673.
Chang, A., Tourtellotte, W. W., Rudick, R. and Trapp, B. D.
(2002). Premyelinating oligodendrocytes in chronic lesions of
multiple sclerosis. N. Engl. J. Med.
346,165
-173.
Chun, S. J., Rasband, M. N., Sidman, R. L., Habib, A. A. and
Vartanian, T. (2003). Integrin-linked kinase is required for
laminin-2-induced oligodendrocyte cell spreading and CNS myelination.
J. Cell Biol. 163,397
-408.
Colognato, H., Baron, W., Avellana-Adalid, V., Relvas, J. B.,
Baron-Van Evercooren, A., Georges-Labouesse, E. and ffrench-Constant, C.
(2002). CNS integrins switch growth factor signalling to promote
target-dependent survival. Nat. Cell Biol.
4, 833-841.[CrossRef][Medline]
Colognato, H., Ramachandrappa, S., Olsen, I. M. and
ffrench-Constant, C. (2004). Integrins direct Src family
kinases to regulate distinct phases of oligodendrocyte development.
J. Cell Biol. 167,365
-375.
Davidson, D., Chow, L. M., Fournel, M. and Veillette, A.
(1992). Differential regulation of T cell antigen responsiveness
by isoforms of the src-related tyrosine protein kinase p59fyn. J.
Exp. Med. 175,1483
-1492.
Fazeli, A., Dickinson, S. L., Hermiston, M. L., Tighe, R. V.,
Steen, R. G., Small, C. G., Stoeckli, E. T., Keino-Masu, K., Masu, M.,
Rayburn, H. et al. (1997). Phenotype of mice lacking
functional Deleted in colorectal cancer (Dcc) gene.
Nature 386,796
-804.[CrossRef][Medline]
Fox, M. A., Afshari, F. S., Alexander, J. K., Colello, R. J. and
Fuss, B. (2006). Growth conelike sensorimotor structures are
characteristic features of postmigratory, premyelinating oligodendrocytes.
Glia 53,563
-566.[CrossRef][Medline]
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S.,
Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A.
(1996). Discovery of a novel, potent, and Src family-selective
tyrosine kinase inhibitor: study of Lck- and FynT-dependent T cell activation.
J. Biol. Chem. 271,695
-701.
Hardy, R. J. and Friedrich, V. L., Jr (1996).
Progressive remodeling of the oligodendrocyte process arbor during
myelinogenesis. Dev. Neurosci.
18,243
-254.[Medline]
Jarjour, A. A. and Kennedy, T. E. (2004).
Oligodendrocyte precursors on the move: mechanisms directing migration.
Neuroscientist 10,99
-105.
Jarjour, A. A., Manitt, C., Moore, S. W., Thompson, K. M., Yuh,
S.-J. and Kennedy, T. E. (2003). Netrin-1 is a chemorepellent
for oligodendrocyte precursor cells in the embryonic spinal cord.
J. Neurosci. 23,3735
-3744.
Kennedy, T. E., Serafini, T., de la Torre, J. R. and
Tessier-Lavigne, M. (1994). Netrins are diffusible
chemotropic factors for commissural axons in the embryonic spinal cord.
Cell 78,425
-435.[CrossRef][Medline]
Kirby, B. B., Takada, N., Latimer, A. J., Shin, J., Carney, T.
J., Kelsh, R. N. and Appel, B. (2006). In vivo
time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during
zebrafish development. Nat. Neurosci.
9,1506
-1511.[CrossRef][Medline]
Knapp, P. E., Bartlett, W. P. and Skoff, R. P.
(1987). Cultured oligodendrocytes mimic in vivo
phenotypic characteristics: cell shape, expression of myelin-specific
antigens, and membrane production. Dev. Biol.
120,356
-365.[CrossRef][Medline]
Li, W., Lee, J., Vikis, H. G., Lee, S. H., Liu, G., Aurandt, J.,
Shen, T. L., Fearon, E. R., Guan, J. L., Han, M. et al.
(2004). Activation of FAK and Src are receptor-proximal events
required for netrin signaling. Nat. Neurosci.
7,1213
-1221.[CrossRef][Medline]
Liang, X., Draghi, N. A. and Resh, M. D.
(2004). Signaling from integrins to Fyn to Rho family GTPases
regulates morphologic differentiation of oligodendrocytes. J.
Neurosci. 24,7140
-7149.
Liu, G., Beggs, H., Jurgensen, C., Park, H. T., Tang, H.,
Gorski, J., Jones, K. R., Reichardt, L. F., Wu, J. and Rao, Y.
(2004). Netrin requires focal adhesion kinase and Src family
kinases for axon outgrowth and attraction. Nat.
Neurosci. 7,1222
-1232.[CrossRef][Medline]
Manitt, C., Colicos, M. A., Thompson, K. M., Rousselle, E.,
Peterson, A. C. and Kennedy, T. E. (2001). Widespread
expression of Netrin-1 by neurons and oligodendrocytes in the adult mammalian
spinal cord. J. Neurosci.
21,3911
-3922.
Meriane, M., Tcherkezian, J., Webber, C. A., Danek, E. I.,
Triki, I., McFarlane, S., Bloch-Gallego, E. and Lamarche-Vane, N.
(2004). Phosphorylation of DCC by Fyn mediates Netrin-1 signaling
in growth cone guidance. J. Cell Biol.
167,687
-698.
Miron, V. E., Rajasekharan, S., Jarjour, A. A., Zamvil, S. S.,
Kennedy, T. E. and Antel, J. P. (2007). Simvastatin regulates
oligodendroglial process dynamics and survival. Glia
55,130
-143.[CrossRef][Medline]
Osterhout, D. J., Wolven, A., Wolf, R. M., Resh, M. D. and Chao,
M. V. (1999). Morphological differentiation of
oligodendrocytes requires activation of Fyn tyrosine kinase. J.
Cell Biol. 145,1209
-1218.
Reid, T., Furuyashiki, T., Ishizaki, T., Watanabe, G., Watanabe,
N., Fujisawa, K., Morii, N., Madaule, P. and Narumiya, S.
(1996). Rhotekin, a new putative target for Rho bearing homology
to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain.
J. Biol. Chem. 271,13556
-13560.
Ren, X. D. and Schwartz, M. A. (2000).
Determination of GTP loading on Rho. Methods Enzymol.
325,264
-272.[Medline]
Ren, X. R., Ming, G. L., Xie, Y., Hong, Y., Sun, D. M., Zhao, Z.
Q., Feng, Z., Wang, Q., Shim, S., Chen, Z. F. et al. (2004).
Focal adhesion kinase in netrin-1 signaling. Nat.
Neurosci. 7,1204
-1212.[CrossRef][Medline]
Ricard, D., Rogemond, V., Charrier, E., Aguera, M., Bagnard, D.,
Belin, M.-F., Thomasset, N. and Honnorat, J. (2001).
Isolation and expression pattern of human Unc-33-like phosphoprotein
6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with
Ulip2/CRMP2 in Sema3A-sensitive oligodendrocytes. J.
Neurosci. 21,7203
-7214.
Sander, E. E., van Delft, S., ten Klooster, J. P., Reid, T., van
der Kammen, R. A., Michiels, F. and Collard, J. G. (1998).
Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either
cell-cell adhesion or cell migration and is regulated by phosphatidylinositol
3-kinase. J. Cell Biol.
143,1385
-1398.
Schwab, M. E. and Schnell, L. (1989).
Region-specific appearance of myelin constituents in the developing rat spinal
cord. J. Neurocytol. 18,161
-169.[CrossRef][Medline]
Serafini, T., Colamarino, S. A., Leonardo, E. D., Wang, H.,
Beddington, R., Skarnes, W. C. and Tessier-Lavigne, M.
(1996). Netrin-1 is required for commissural axon guidance in the
developing vertebrate nervous system. Cell
87,1001
-1014.[CrossRef][Medline]
Shekarabi, M. and Kennedy, T. E. (2002). The
netrin-1 receptor DCC promotes filopodia formation and cell spreading by
activating Cdc42 and Rac1. Mol. Cell. Neurosci.
19, 1-17.[CrossRef][Medline]
Shekarabi, M., Moore, S. W., Tritsch, N. X., Morris, S. J.,
Bouchard, J. F. and Kennedy, T. E. (2005). Deleted in
colorectal cancer binding netrin-1 mediates cell substrate adhesion and
recruits Cdc42, Rac1, Pak1, and N-WASP into an intracellular signaling complex
that promotes growth cone expansion. J. Neurosci.
25,3132
-3141.
Simons, M. and Trotter, J. (2007). Wrapping it
up: the cell biology of myelination. Curr. Opin.
Neurobiol. 17,533
-540.[CrossRef][Medline]
Sloane, J. A. and Vartanian, T. K. (2007).
WAVE1 and regulation of actin nucleation in myelination.
Neuroscientist 13,486
-491.
Smart, J. E., Oppermann, H., Czernilofsky, A. P., Purchio, A.
F., Erikson, R. L. and Bishop, J. M. (1981). Characterization
of sites for tyrosine phosphorylation in the transforming protein of Rous
sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).
Proc. Natl. Acad. Sci. USA
78,6013
-6017.
Sperber, B. R., Boyle-Walsh, E. A., Engleka, M. J., Gadue, P.,
Peterson, A. C., Stein, P. L., Scherer, S. S. and McMorris, F. A.
(2001). A unique role for Fyn in CNS myelination. J.
Neurosci. 21,2039
-2047.
Thurnherr, T., Benninger, Y., Wu, X., Chrostek, A., Krause, S.
M., Nave, K. A., Franklin, R. J., Brakebusch, C., Suter, U. and Relvas, J.
B. (2006). Cdc42 and Rac1 signaling are both required for and
act synergistically in the correct formation of myelin sheaths in the CNS.
J. Neurosci. 26,10110
-10119.
Tsai, H. H., Tessier-Lavigne, M. and Miller, R. H.
(2003). Netrin 1 mediates spinal cord oligodendrocyte precursor
dispersal. Development
130,2095
-2105.
Tsai, H. H., Macklin, W. B. and Miller, R. H.
(2006). Netrin-1 is required for the normal development of spinal
cord oligodendrocytes. J. Neurosci.
26,1913
-1922.
Umemori, H., Sato, S., Yagi, T., Aizawa, S. and Yamamoto, T.
(1994). Initial events of myelination involve Fyn tyrosine kinase
signalling. Nature 367,572
-576.[CrossRef][Medline]
Watanabe, M., Sakurai, Y., Ichinose, T., Aikawa, Y., Kotani, M.
and Itoh, K. (2006). Monoclonal antibody Rip specifically
recognizes 2',3'-cyclic nucleotide 3'-phosphodiesterase in
oligodendrocytes. J. Neurosci. Res.
84,525
-533.[CrossRef][Medline]
Wolf, R. M., Wilkes, J. J., Chao, M. V. and Resh, M. D.
(2001). Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates
oligodendrocyte differentiation. J. Neurobiol.
49, 62-78.[CrossRef][Medline]
Yebra, M., Montgomery, A. M., Diaferia, G. R., Kaido, T.,
Silletti, S., Perez, B., Just, M. L., Hildbrand, S., Hurford, R., Florkiewicz,
E. et al. (2003). Recognition of the neural chemoattractant
Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell
adhesion and migration. Dev. Cell
5, 695-707.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
P.-S. Wang, J. Wang, Z.-C. Xiao, and C. J. Pallen Protein-tyrosine Phosphatase {alpha} Acts as an Upstream Regulator of Fyn Signaling to Promote Oligodendrocyte Differentiation and Myelination J. Biol. Chem., November 27, 2009; 284(48): 33692 - 33702. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||